ELIXIRGEN THERAPEUTICS
Live / Applied — Fifth extension granted (statement of use) (as of 01 May 2025)
What this means for you
Not registered yet, but its 01 Dec 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97150473
- Mark type
- Stylized text
- Filed
- 01 Dec 2021
- Published for opposition
- 28 Feb 2023
- Attorney of record
- Leonard D. Bowersox
Goods and services
- Class 035 — Advertising and business services: Retail store services featuring pharmaceutical drugs and chemical preparations for cell and gene therapy
Owner
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
Prosecution history
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 5 GRANTED
- 24 Apr 2025 — SOU EXTENSION 5 FILED
- 01 May 2025 — SOU EXTENSION 4 GRANTED
- 24 Apr 2025 — SOU EXTENSION 4 FILED
- 24 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2024 — SOU EXTENSION 3 GRANTED
- 21 Oct 2024 — SOU EXTENSION 3 FILED
- 21 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 20 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Apr 2024 — SOU EXTENSION 2 GRANTED
- 19 Apr 2024 — SOU EXTENSION 2 FILED
- 19 Apr 2024 — SOU TEAS EXTENSION RECEIVED